MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 201 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,821,990 | +1014.2% | 4,382,199 | +1285.0% | 0.02% | +1050.0% |
| Q2 2023 | $3,933,014 | +2693745.2% | 316,413 | +2944.5% | 0.00% | – |
| Q1 2023 | $146 | -99.6% | 10,393 | -99.6% | 0.00% | -100.0% |
| Q4 2022 | $37,571 | -99.9% | 2,625,548 | +38.9% | 0.02% | -25.0% |
| Q3 2022 | $48,254,000 | +797.4% | 1,890,074 | +898.7% | 0.03% | +833.3% |
| Q2 2022 | $5,377,000 | -77.1% | 189,253 | -71.5% | 0.00% | -75.0% |
| Q1 2022 | $23,443,000 | +7.3% | 664,679 | +27.4% | 0.01% | +9.1% |
| Q4 2021 | $21,856,000 | +17.6% | 521,619 | +37.7% | 0.01% | 0.0% |
| Q3 2021 | $18,589,000 | +17.6% | 378,750 | +0.0% | 0.01% | +10.0% |
| Q2 2021 | $15,801,000 | +21.3% | 378,650 | +3.6% | 0.01% | +11.1% |
| Q1 2021 | $13,030,000 | -34.2% | 365,605 | -48.2% | 0.01% | -35.7% |
| Q4 2020 | $19,795,000 | – | 705,698 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |